Stay updated with breaking news from Particle Sciences. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The US Food and Drug Administration (FDA) has approved a topical foam developed by Arcutis Biotherapeutics and branded as Zoryve for the skin condition seborrheic dermatitis in people aged nine years and up.
The US contract development and manufacturing organization (CDMO) Agno Pharma has taken over compatriot firm Lubrizol Particle Sciences to increase its drug product formulation offerings.
Agno Pharma, a pharmaceutical company, will acquire the Lubrizol Particle Sciences business, including a Northampton County development and manufacturing site with about 65 employees.
![Bioanalytical Testing Services Market 2023 Segment [Type, Applications, Players, Regions] Analysis – Hometown Pages - Vimarsana News](https://vimarsana.com/images/vimarsana-bigimage.jpg)
Press Release - July 20, 2023, (Orbisresearch.com) - A newest research report titled, “Global Bioanalytical Testing Services Market
Between 2022 and 2035, the bioavailability enhancement services market will see an 11 percent CAGR, a report has predicted.